Study Conduct

Merz Pharmaceuticals, SAFE to launch patient-centric spasticity initiative

Tuesday, February 28, 2017

Merz Pharmaceuticals has announced the launch of Life With Spasticity, an educational online platform intended to provide comprehensive information and motivational support for stroke survivors who experience post-stroke spasticity. Designed by and for individuals living with spasticity, the project is funded by Merz and has been developed in partnership with Stroke Alliance For Europe (SAFE).

[Read More]

My Life, Our Future opens genetic hemophilia repository to scientists

Tuesday, February 28, 2017

My Life, Our Future, a national program founded by the bleeding disorder community, including Bloodworks Northwest, the American Thrombosis and Hemostasis Network, the National Hemophilia Foundation and Bioverativ, opened the largest research repository of its kind in the world to scientists. The My Life, Our Future Research Repository is a collection of genetic data and blood samples that are linked to phenotypic data from more than 5,000 people in the U.S. with hemophilia, a rare disorder that impairs the ability of one’s blood to clot. The My Life, Our Future Research Repository will allow researchers to advance the scientific understanding of the disorder, including genetic differences that affect bleeding severity and reaction to certain treatments. 

[Read More]

INC Research adds investigator payment offering

Thursday, February 23, 2017

INC Research, a global phase I to IV CRO, has announced expansion of its Functional Service Provider (FSP) service offering to include investigator payment processing, leveraging the company’s extensive expertise and delivery of customized solutions in this area as well as insights gained from its industry-recognized site relationships. The addition of investigator payment processing to the company’s FSP offering builds on its nearly 20 years of experience in meeting the needs of biopharmaceutical customers worldwide for standalone outsourced services under an FSP model, including Data Management, Medical Writing, Safety and Pharmacovigilance, and Site Contracts.

[Read More]

Survey: Patients access to medical records critical to high-quality healthcare

Wednesday, February 22, 2017

In the era of digital health, patients have very high expectations for medical information sharing, but they may not be aware of the healthcare industry’s current limitations. That’s according to a new digital health survey released today by Transcend Insights, a population health management company. The survey found that a vast majority of patients (97%) believe it is important for any health institution, regardless of type or location, to have access to their full medical history in order to receive high-quality care.

[Read More]

Pediatric hematology-oncology initiative launched in Africa

Tuesday, February 21, 2017

His Excellency the President Lieutenant General Dr. Seretse Khama Ian Khama of the Republic of Botswana, the Honorable Minister Dorcas Makgato of the Ministry of Health and Wellness, the Bristol-Myers Squibb Foundation, Texas Children’s Cancer and Hematology Centers (TXCH) and Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children’s Hospital (BIPAI) through public-private partnerships with the governments of Botswana, Uganda and Malawi, announced a $100 million initiative to create an innovative pediatric hematology-oncology treatment network in southern and east Africa. The comprehensive initiative called Global HOPE (Hematology-Oncology Pediatric Excellence) will build long-term capacity to treat and dramatically improve the prognosis of thousands of children with cancer and blood disorders in southern and eastern Africa.

[Read More]

Clinerion and ASUS Life partner in Taiwan

Thursday, February 16, 2017

Clinerion and ASUS Life signed a strategic alliance. Clinerion and ASUS Life, together with the Show Chwan Healthcare System, will deliver innovative services for the efficient running of clinical trials, clinical patient recruitment, market access and real-world evidence in Taiwan.

[Read More]